參考文獻(xiàn)/References:
[1] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診治指南(2011年)[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2011,4(1):2-17.
[2] 陳瑾瑜,游利,潘凌,等.老年患者脆性骨折1072例分析[J].世界臨床藥物,2016,37(6):385-389.
[3] 黃淑紓,林華,朱秀芬,等.骨質(zhì)量與骨質(zhì)疏松性骨折[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2012,5(4):285-291.
[4] MORI S.Contribution of bone quality to fracture risk[J].Clin Calcium,2004,14(10):33-38.
[5] 王桂華.骨質(zhì)量的影響因素及其檢測方法[J].醫(yī)學(xué)研究生學(xué)報,2011,24(10):1095-1098.
[6] 郭世紱.骨質(zhì)量與骨質(zhì)疏松癥[J].國外醫(yī)學(xué)(內(nèi)分泌學(xué)分冊),2005,25(5):295-297.
[7] 黃立莉,洪文,王立源,等.絕經(jīng)后骨質(zhì)疏松癥的臨床治療進(jìn)展[J].中國醫(yī)藥導(dǎo)報,2011,8(18):7-10.
[8] 王鷗,邢小平.老年性骨質(zhì)疏松癥發(fā)病機(jī)制及藥物治療進(jìn)展[J].中國實用內(nèi)科雜志,2011,31(8):584-586.
[9] 楊濤濤,呂曉紅,任鳳華,等.老年骨質(zhì)疏松性骨折患者的危險因素與干預(yù)措施[J].現(xiàn)代預(yù)防醫(yī)學(xué),2012,39(11):2756-2757.
[10] 寧娟.老年骨質(zhì)疏松性骨折患者的危險因素與護(hù)理干預(yù)措施[J].中國衛(wèi)生產(chǎn)業(yè),2012,9(10):32-33.
[11] KANIS JA,BORGSTROM F,DE LAET C,et al.Assessment of fracture risk[J].Osteoporos Int,2005,16(6):581-589.
[12] KANIS JA,JOHNELL O,ODEN A,et al.FRAX and the assessment of fracture probability in men and women from the UK[J].Osteoporos Int,2008,19(4):385-397.
[13] RAJAMANOHARA R,ROBINSON J,RYMER J,et al.The effect of weight and weight change on the long-term precision of spine and hip DXA measurements[J].Osteoporos Int,2011,22(5):1503-1512.
[14] 楊丹,粟平,趙平.探討骨質(zhì)疏松性骨折的相關(guān)影響因素及預(yù)防[J].中國骨質(zhì)疏松雜志,2014,20(2):152-155.
[15] 鄧介超,唐海,朱富強,等.FRAX在中國絕經(jīng)后女性人群骨折風(fēng)險預(yù)測中的適用性評價[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2012,5(4):247-254.
[16] 張智海,高冰,劉忠厚.應(yīng)用骨折風(fēng)險因子評估工具(FRAX)診治骨質(zhì)疏松癥[J].中國骨質(zhì)疏松雜志,2012,18(7):589-595.
[17] 朱再勝,章振林.骨折風(fēng)險評估工具(FRAX(R))對絕經(jīng)后低骨量女性骨折的預(yù)測價值[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2013,6(3):213-218.
[18] 馮穎瑜.骨質(zhì)疏松癥的藥物治療[J].醫(yī)學(xué)綜述,2014,20(1):105-109.
[19] 廖二元.骨質(zhì)疏松防治的現(xiàn)狀與進(jìn)展[J].藥品評價,2013,10(5):15-21.
[20] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會,中華醫(yī)學(xué)會骨科學(xué)分會骨質(zhì)疏松學(xué)組.骨質(zhì)疏松性骨折患者抗骨質(zhì)疏松治療與管理專家共識[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2015,8(3):189-195.
[21] 李國德.骨質(zhì)疏松癥的中醫(yī)藥治療概述[J].中國老年保健醫(yī)學(xué),2010,8(4):69-70.
[22] 彭麗紅,馬改霞.骨質(zhì)疏松癥的中醫(yī)藥治療研究進(jìn)展[J].西北藥學(xué)雜志,2013,28(1):98-101.
[23] 嚴(yán)紅梅,張振海,孫娥,等.中藥治療骨質(zhì)疏松癥的研究進(jìn)展[J].中草藥,2014,45(8):1174-1178.
[24] 李春雯,毛應(yīng)德龍,史曉林.強骨飲對去勢大鼠股骨頸骨形態(tài)計量學(xué)的影響[J].中國骨質(zhì)疏松雜志,2007,13(6):433-435.
相似文獻(xiàn)/References:
[1]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[2]徐偉鋒,葉健,吳連國.強骨飲對骨質(zhì)疏松性股骨頸骨折患者全髖關(guān)節(jié)置換術(shù)后
血清骨代謝生化指標(biāo)和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):12.
[3]龔江浩.股骨近端防旋髓內(nèi)釘聯(lián)合抗骨質(zhì)疏松藥物治療
不穩(wěn)定型老年股骨轉(zhuǎn)子間骨折的臨床觀察[J].中醫(yī)正骨,2015,27(04):29.
GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):29.
[4]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[5]陳建德,樊曉琦,夏炳江,等.球囊擴(kuò)張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):11.
[6]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):1.
[7]陳勍,劉鐘,陳文亮,等.股骨近端防旋髓內(nèi)釘固定聯(lián)合口服仙靈骨葆膠囊治療腎陽虛型骨質(zhì)疏松性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2017,29(07):69.
[8]曾武,林曙峰,朱俊峰,等.女性骨質(zhì)疏松性橈骨遠(yuǎn)端骨折鎖定鋼板內(nèi)固定術(shù)后腕關(guān)節(jié)功能恢復(fù)的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):39.
[9]孫龍?zhí)?姚華海,王曉洛,等.強骨飲對假體周圍骨溶解模型大鼠骨密度的影響及其作用機(jī)制研究[J].中醫(yī)正骨,2017,29(09):19.
SUN Longtai,YAO Huahai,WANG Xiaoluo,et al.Effect of Qianggu Yin(強骨飲)on bone density of peri-prosthetic osteolysis rat models and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):19.
[10]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(05):1.
[11]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[12]吳鵬,王博,孔令成,等.強骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):16.
[13]黃俊俊,史曉林,鄧祖躍.強骨飲對骨質(zhì)疏松性骨折愈合的影響及其作用機(jī)制[J].中醫(yī)正骨,2018,30(09):10.
HUANG Junjun,SHI Xiaolin,DENG Zuyue.Effects of Qianggu Yin(強骨飲)on the healing of osteoporotic fracture and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(05):10.